ORTEXORTEX News
Tracking FIX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
FI
Earnings PreviewFIX

FIX Drops 22% in a Month, But Short Sellers Are Absent

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 23 Oct 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Comfort Systems USA has shed 22% over the past month to close at $1,279.37, roughly three times the decline of most peers, yet the mechanics of a stock under genuine short pressure are nowhere to be found.

The options market is the most telling data point heading into today's print. The put/call ratio has dropped to 1.10, two standard deviations below its 20-day average of 1.23. That is the lowest defensive positioning in a year, and it has moved in lockstep with the sell-off rather than against it: as the stock fell 13.6% on the week, call demand rose relative to puts. The peer context matters here. EMCOR Group fell 6.2% on the week, Quanta Services dropped 9.0%, and IES Holdings lost 11.2%. FIX's decline is at the steeper end of a sector-wide move, but options traders are treating it as an opportunity rather than a reason to hedge.

Short interest reinforces that picture. At 2.3% of the free float, it has actually fallen 14% over the past month, moving away from even its already low base. Borrow availability is entirely unconstrained: 34.8 million shares are available to lend against short positions of roughly 825,000 shares. Cost to borrow is 0.36%, barely changed on the week. There is no evidence of short sellers building a position into the weakness.

The central debate around FIX is one of concentration versus quality. Bulls point to a $14.1 billion backlog, $1.8 billion of net cash, peer-leading margins, and a modular manufacturing platform that has grown at close to a 50% compound annual rate since 2021. Capacity is set to reach 5 million square feet by mid-2027, potentially adding more than $800 million in annualised sales. Analysts remain firmly positive: Goldman Sachs initiated at Buy in July with a $2,159 target, and Keybanc raised its target to $2,125 as recently as October 15, both well above the current price. The mean target across covering analysts is $2,163. Bears counter that the growth story depends heavily on a narrow set of hyperscaler customers, that broader nonresidential construction spending is running at minus 5% year on year, and that the stock's price-to-earnings multiple has compressed sharply but still sat at 22 times before today's report. Insiders have been net sellers: the CEO sold $25.8 million of stock in August, and combined C-suite and director sales have totalled more than $56 million over the past 90 days, none of it under a 10b5-1 plan.

Wikipedia attention for FIX has jumped to a z-score of 2.1 against its own 90-day history, the highest retail attention reading in recent months. That elevated attention, arriving just as the stock trades at a 22% discount to its one-month high, sets up today's print as a test of whether the backlog and margin story can justify re-engagement at these levels or whether the hyperscaler concentration risk the bears cite has become harder to dismiss.

Stocks in this article

See the live data behind this article on ORTEX.

Open FIX on ORTEX →

How this article was generated

Generated
23 Oct 2026, 04:03
Data as of
23 Oct 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.